Lrrc32 - leucine rich repeat containing 32

Predicted to enable transforming growth factor beta binding activity. Predicted to be involved in regulation of transforming growth factor beta3 activation; secondary palate development; and transforming growth factor beta receptor signaling pathway. Predicted to act upstream of or within negative regulation of activated T cell proliferation; negative regulation of cytokine production; and positive regulation of gene expression. Predicted to be located in cell surface and nucleoplasm. Orthologous to human LRRC32 (leucine rich repeat containing 32). [provided by Alliance of Genome Resources, Apr 2022]